1-[4-(4,5-dihydro-1H-imidazol-2-yl)aminophenyl]-3-(substituted phenyl)-2-propene-1-one as antiparkinsonian agents.
作者信息
Srivastava V K, Singh S, Palit G, Shanker K
出版信息
Pharmazie. 1986 Aug;41(8):598-9.
PMID:3786386
Abstract
摘要
相似文献
1
2
3-[5-(4,5-dihydro-1H-imidazol-2-yl)-furan-2-yl]phenylamine (Amifuraline), a promising reversible and selective peripheral MAO-A inhibitor.3-[5-(4,5-二氢-1H-咪唑-2-基)-呋喃-2-基]苯胺（阿米呋喃林），一种有前景的可逆性和选择性外周单胺氧化酶-A抑制剂。
J Med Chem. 2006 Sep 7;49(18):5578-86. doi: 10.1021/jm060605r.
3
4
[Substances with antibacterial and antifungal activity. I. Synthesis and microbiologic activity of imidazolylmethylanilines].
Farmaco Sci. 1986 Apr;41(4):292-307.
5
(+/-)-1-(Adamantan-2-yl)-2-propanamine and other amines derived from 2-adamantanone.
Farmaco Sci. 1980 May;35(5):430-40.
6
Newer dopamine quinazolones as anti-parkinsonian agents.新型多巴胺喹唑啉类药物作为抗帕金森病药物
Pharmazie. 1985 Apr;40(4):267-8. doi: 10.1002/chin.198531244.
7
Discovery and SAR development of 2-(phenylamino) imidazolines as prostacyclin receptor antagonists [corrected].2-（苯胺基）咪唑啉类作为前列环素受体拮抗剂的发现与构效关系研究[已校正]
Bioorg Med Chem Lett. 2004 Feb 23;14(4):1053-6. doi: 10.1016/j.bmcl.2003.10.070.
8
Substituted dopamine quinazolones as potent antiparkinsonian agents.
Pharmazie. 1981 Nov;36(11):780.
9
Zotero 插件